Stock SNPX SYNAPTOGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Synaptogenix, Inc.

Equities

SNPX

US87167T3005

Delayed Nasdaq
Other stock markets
 02:23:38 2024-05-17 pm EDT 		5-day change 1st Jan Change
4.834 USD -1.55% Intraday chart for Synaptogenix, Inc. +5.77% -28.89%
Apr. 09 Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. CI
Apr. 03 Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Synaptogenix, Inc. Announces Resignation of George Perry from the Board of Directors and as Member of All Committees of the Board
CI
Neurotrope Bioscience, Inc. has Changed its Name to Synaptogenix, Inc
CI
Neurotrope Bioscience, Inc. Appoints Paula T. Trzepacz as Executive Vice President and Chief Medical Officer
CI
Neurotrope Bioscience, Inc. Announces Resignation of Warren Wasiewski as Executive Vice President, Development
CI
Neurotrope Bioscience, Inc. Announces Executive Changes
CI
Neurotrope, Inc. and Neurotrope Bioscience, Inc. Announce Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SNPX Stock
  4. News Synaptogenix, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW